Medicines – Conclusion of a non-exclusive discount agreement for medicinal products containing darifenacin for the period 01/07/2026–30/06/2028 (plus 1x12-month extension option)

Summary

This tender concerns the supply of medicines containing darifenacin and the conclusion of a drug discount agreement between DAK-Gesundheit and as many interested pharmaceutical companies as possible. The agreement starts on 01/07/2026 and ends on 30/06/2028, with an option to extend once by 12 months. The machine-readable notice did not include precise selection, exclusion or compliance requirements; these must be checked in the tender documents.